| Clinical pharmacology, biomarkers and personalized medicine: education please. | |
| | |
MedLine Citation:
|
PMID: 20477707 Owner: NLM Status: PubMed-not-MEDLINE |
Abstract/OtherAbstract:
|
Over the past decades, the scope of clinical pharmacology within the pharmaceutical industry has widened considerably. Key growth has been in the area of translational science and exploratory medicine, where clinical pharmacologists are nowadays the mediator between basic research and establishment of clinical usefulness. This role has led to and is supported by the rapid developments in pharmacokinetic-pharmacodynamic modeling and simulation, a strong focus on biomarkers for early informed decision-making, and the advent of pharmacogenomics into safety and efficacy predictions and evaluations. The ultimate goal--safer, more efficacious drug prescription--is shared with that of today's drive for more personalized medicine. This article reviews the evolution of clinical pharmacology within the industry, the regulatory, clinical and societal drivers for this evolution, and the analogy with the establishment of personalized medicine in clinical practice. Special attention is given to the integration of biomarkers into clinical practice and the concurrent need for education of clinicians, pharmacists, payers and patients. |
| | |
Authors:
|
Paul de Koning; James Keirns |
Related Documents
:
|
7228527 - Experiences in teaching psychodynamic orientation. 21922027 - The practice of evidence-based medicine (ebm) in gastroenterology: discrepancies betwee... 21641517 - Are complementary medicine practitioners implementing evidence based practice? 18974647 - Frequency and case identification of dementia with lewy bodies using the revised consen... 8952757 - Management of the antiphospholipid syndrome. main trends, unsolved questions, practical... 5784117 - Changing drug patterns in the haight-ashbury. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Biomarkers in medicine Volume: 3 ISSN: 1752-0371 ISO Abbreviation: Biomark Med Publication Date: 2009 Dec |
Date Detail:
|
Created Date: 2010-05-18 Completed Date: 2010-06-11 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101312535 Medline TA: Biomark Med Country: England |
Other Details:
|
Languages: eng Pagination: 685-700 Citation Subset: - |
Affiliation:
|
Exploratory Development Department, Astellas Pharma Global Development-Europe, Elisabethhof 1, 2353 EW Leiderdorp, The Netherlands. paul.dekoning@eu.astellas.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Clinical pharmacology: a paradigm for individualized medicine.
Next Document: Personalized healthcare: how to improve outcomes by increasing benefit and decreasing risk through t...